VRPX(Delisted)
VirpaxยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About VRPX
Virpax Pharmaceuticals, Inc.
A company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications
1055 Westlakes Drive, Suite 300, Berwyn, PA 19312
--
Virpax Pharmaceuticals, Inc., was incorporated in Delaware on May 12, 2017. The Company is a preclinical stage pharmaceutical company focused on developing novel proprietary drug delivery systems across various pain indications to enhance adherence and optimize each product candidate under development. The Company's drug delivery systems and drug release technologies under development focus on advancing non-opioid and non-addictive pain management treatments and the treatment of central nervous system (" CNS ") diseases to improve the quality of life of patients.
Company Financials
EPS
VRPX has released its 2023 Q3 earnings. EPS was reported at -0.51, versus the expected 0, missing expectations. The chart below visualizes how VRPX has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
